Correction

The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib

Correction Details

Nature of Retraction:

Correction

Retraction Notice:
10.1111/bjh.15766
Additional Notes:

Girija Dasmahapatra has an ORI finding of research misconduct;

Citations (81)

81
Total Citations
17
Post-Retraction
(21.0%)
54
Pre-Retraction
1
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
3 Within 1 year
9 After 2+ years
2083 Days since retraction (latest)
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Oct 2015
1236 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Oct 2015
1236 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Jul 2015
1300 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Jul 2015
1315 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Jul 2015
1316 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Jun 2015
1336 days before retraction
Paper citing Carfilzomib Interacts Synergistically with Histone...
Unknown Authors
Unknown Journal
Published: Jun 2015
1354 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Apr 2015
1417 days before retraction
The tumor microenvironment shapes hallmarks of mature B-cell malignancies
Kenneth H. Shain, William S. Dalton, Jianguo Tao
Oncogene Open Access
Published: Feb 2015
93 citations
1477 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Jan 2015
1490 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Jan 2015
1509 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Oct 2014
1572 days before retraction
Paper citing Role of CAAT/Enhancer Binding Protein Homologous P...
Unknown Authors
Unknown Journal
Published: Sep 2014
1603 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Sep 2014
1616 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Sep 2014
1624 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Aug 2014
1662 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Aug 2014
1662 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Jul 2014
1681 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Jun 2014
1700 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Jun 2014
1706 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Feb 2014
1824 days before retraction
Recent advances in mantle cell lymphoma: report of the 2013 Mantle Cell Lymphoma Consortium Workshop
Leo I. Gordon, Steven H. Bernstein, Pedro Jares et al. (6 authors)
Leukemia & lymphoma/Leukemia and lymphoma
Published: Feb 2014
8 citations
1833 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Jan 2014
1847 days before retraction
Targeting Mantle Cell Lymphoma with a Strategy of Combined Proteasome and Histone Deacetylase Inhibition
Michael Batalo, Prithviraj Bose, Beata Holkova et al. (4 authors)
Resistance to targeted anti-cancer therapeutics
Published: Jan 2014
3 citations
1874 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Jan 2014
1874 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Oct 2013
1966 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Sep 2013
1996 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Aug 2013
2001 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Jul 2013
2038 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Jul 2013
2043 days before retraction
Paper citing The Bruton tyrosine kinase (BTK) inhibitor PCI-327...
Unknown Authors
Unknown Journal
Published: Jun 2013
2088 days before retraction
Quick Stats
Total Citations: 81
Years Since Retraction: 6.8 years
Open Access: Yes
Last Checked: Never
Related Papers
First report of novel heterozygous WRAP53 p.Ala522Glyfs*8 m…
British Journal of Haematology • 8 citations
Chrysophanol suppresses growth and metastasis of T cell acu…
Naunyn-Schmiedeberg's Archives of Pharmacology • 11 citations
Chrysophanol suppresses growth and metastasis of T cell acu…
Naunyn-Schmiedeberg's Archives of Pharmacology • 12 citations